Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi

European Journal of Pharmacology

Volumn 745, Issue , 2014, Pages 135-143

  Cazzola, Mario ^a   Calzetta, Luigino ^b   Page, Clive P ^c   Rogliani, Paola ^a   Facciolo, Francesco ^d   Gavaldà, Amadeu ^e   Matera, Maria Gabriella ^f  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e Almirall Respiratory Therapeutic Area Discovery R and D Center Sant Feliu de Llobregat ^*  (Spain)

^f SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

COPD; Human bronchi; LABA; LAMA; Synergistic interaction

Indexed keywords

ACETYLCHOLINE; ACLIDINIUM BROMIDE; FORMOTEROL FUMARATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; ETHANOLAMINE DERIVATIVE; FORMOTEROL; MUSCARINIC RECEPTOR BLOCKING AGENT; TROPANE DERIVATIVE;

ADULT; AIRWAY; ARTICLE; BREATHING MUSCLE; BRONCHIOLE; BRONCHODILATATION; BRONCHUS; CLINICAL ARTICLE; DRUG POTENTIATION; ELECTRIC FIELD; ELECTROSTIMULATION; FEMALE; HUMAN; HUMAN TISSUE; ISOLATED ORGAN; MALE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE RELAXATION; AGED; BIOLOGICAL MODEL; DOSE RESPONSE; DRUG EFFECTS; IN VITRO STUDY; MIDDLE AGED; MUSCLE RELAXATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BRONCHI; BRONCHIOLES; BRONCHODILATOR AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTRIC STIMULATION; ETHANOLAMINES; FEMALE; HUMANS; IN VITRO TECHNIQUES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MUSCARINIC ANTAGONISTS; MUSCLE RELAXATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SIGNAL TRANSDUCTION; TROPANES;

EID: 84919360274     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.10.025     Document Type: Article

References (46)

1. P.J. Barnes Distribution of receptor targets in the lung Proc. Am. Thorac. Soc. 1 2004 345 351
2. M.C. Berenbaum What is synergy? Pharmacol. Rev. 41 1989 93 141
3. J.C. Boik, R.A. Newman, and R.J. Boik Quantifying synergism/antagonism using nonlinear mixed-effects modeling: a simulation study Stat. Med. 27 2008 1040 1061
4. A.N. Boucher, and V.H. Tam Mathematical formulation of additivity for antimicrobial agents Diagn. Microbiol. Infect. Dis. 55 2006 319 325
5. T. Bouyssou, P. Casarosa, M. Pieper, A. Schnapp, and F. Gantner Synergistic bronchoprotective activity of the long-acting beta 2-agonist olodaterol with tiotropium (long-acting M3 antagonist) and ciclesonide (inhaled steroid) on the ovalbumin-induced bronchoconstriction in anaesthetized guinea pigs Eur. Respir. J. 38 Suppl. 55 2011 613s
6. T. Bouyssou, A. Schnapp, P. Casarosa, and M. Pieper Addition Of The New Once-daily LABA BI 1744 to tiotropium results in superior bronchoprotection in pre-clinical models Am. J. Respir. Crit. Care Med. 181 2010
7. L. Calzetta, C.P. Page, D. Spina, M. Cazzola, P. Rogliani, F. Facciolo, and M.G. Matera Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone J. Pharmacol. Exp. Ther. 346 2013 414 423
8. L. Calzetta, D. Passeri, V. Kanabar, P. Rogliani, C. Page, M. Cazzola, M.G. Matera, and A. Orlandi Brain natriuretic peptide protects against hyperresponsiveness of human asthmatic airway smooth muscle via an epithelial cell-dependent mechanism Am. J. Respir. Cell Mol. Biol. 50 2014 493 501
9. L. Calzetta, P. Rogliani, M. Cazzola, and M.G. Matera Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond Expert Opin.Drug Discov 2014
10. L. Calzetta, D. Spina, M. Cazzola, C.P. Page, F. Facciolo, E.A. Rendina, and M.G. Matera Pharmacological characterization of adenosine receptors on isolated human bronchi Am. J. Respir. Cell Mol. Biol. 45 2011 1222 1231
11. M. Cazzola, L. Calzetta, C.P. Page, B. Rinaldi, A. Capuano, and M.G. Matera Protein prenylation contributes to the effects of LPS on EFS-induced responses in human isolated bronchi Am. J. Respir. Cell Mol. Biol. 45 2011 704 710
12. M. Cazzola, L. Calzetta, P. Rogliani, D. Lauro, L. Novelli, C.P. Page, V. Kanabar, and M.G. Matera High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway Am. J. Respir. Cell Mol. Biol. 47 2012 509 516
13. M. Cazzola, L. Calzetta, A. Segreti, F. Facciolo, P. Rogliani, and M.G. Matera Translational study searching for synergy between glycopyrronium and indacaterol COPD 2014
14. M. Cazzola, and M.G. Matera Novel long-acting bronchodilators for COPD and asthma Br. J. Pharmacol. 155 2008 291 299
15. M. Cazzola, and M. Molimard The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD Pulm. Pharmacol. Ther. 23 2010 257 267
16. M. Cazzola, A. Segreti, and M.G. Matera New developments in the combination treatment of COPD: focus on umeclidinium/vilanterol Drug Des. Dev. Ther. 7 2013 1201 1208
17. M. Cazzola, and D.P. Tashkin Combination of formoterol and tiotropium in the treatment of COPD: effects on lung function COPD 6 2009 404 415
18. A. D'Urzo, S. Rennard, V. Mergel, E. Garcia Gil, A. Leselbaum, and C. Caracta The AUGMENT COPD trial: efficacy and safety of a fixed-dose combination of aclidinium bromide and formoterol fumarate in COPD patients Chest 145 2014 426A
19. M. Endoh, and M. Hori Acute heart failure: inotropic agents and their clinical uses Expert Opin. Pharmacother. 7 2006 2179 2202
20. W. Freas, J.L. Hart, D. Golightly, H. McClure, and S.M. Muldoon Contractile properties of isolated vascular smooth muscle after photoradiation Am. J. Physiol. 256 1989 H655 H664
21. GINA Global Strategy for Asthma Management and Prevention 2012 Global Initiative for Asthma (GINA) http://www.ginasthma.org/
22. GOLD Global Strategy for the Diagnosis, Management and Prevention of COPD 2014 Global Initiative for Chronic Obstructive Lung Disease (GOLD) http://www.goldcopd.org/
23. M. Goldoni, and C. Johansson A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model Toxicol. In Vitro 21 2007 759 769
24. W.R. Greco, G. Bravo, and J.C. Parsons The search for synergy: a critical review from a response surface perspective Pharmacol. Rev. 47 1995 331 385
25. K. Hatake, and I. Wakabayashi Ethanol suppresses l-arginine-induced relaxation response of rat aorta stimulated with bacterial lipopolysaccharide Nihon Arukoru Yakubutsu Igakkai Zasshi 35 2000 61 68
26. C.A. Hewson, S. Patel, L. Calzetta, H. Campwala, S. Havard, E. Luscombe, P.A. Clarke, P.T. Peachell, M.G. Matera, M. Cazzola, C. Page, W.M. Abraham, C.M. Williams, J.D. Clark, W.L. Liu, N.P. Clarke, and M. Yeadon Preclinical evaluation of an inhibitor of cytosolic phospholipase A2alpha for the treatment of asthma J. Pharmacol. Exp. Ther. 340 2012 656 665
27. A.R. Hulsmann, and J.C. de Jongste Studies of human airways in vitro: a review of the methodology J. Pharmacol. Toxicol. Methods 30 1993 117 132
28. M. Iglarz, C. Binkert, K. Morrison, W. Fischli, J. Gatfield, A. Treiber, T. Weller, M.H. Bolli, C. Boss, S. Buchmann, B. Capeleto, P. Hess, C. Qiu, and M. Clozel Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist J. Pharmacol. Exp. Ther. 327 2008 736 745
29. S.I. Lee Drug interaction: focusing on response surface models Korean J. Anesthesiol. 58 2010 421 434
30. M.G. Matera, L. Calzetta, V. Parascandolo, G. Curradi, P. Rogliani, and M. Cazzola Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi Pulm. Pharmacol. Ther. 22 2009 478 482
31. M.G. Matera, L. Calzetta, D. Passeri, F. Facciolo, E.A. Rendina, C. Page, M. Cazzola, and A. Orlandi Epithelium integrity is crucial for the relaxant activity of brain natriuretic peptide in human isolated bronchi Br. J. Pharmacol. 163 2011 1740 1754
32. M.G. Matera, L. Calzetta, A. Peli, A. Scagliarini, C. Matera, and M. Cazzola Immune sensitization of equine bronchus: glutathione, IL-1beta expression and tissue responsiveness Respir. Res. 6 2005 104
33. M.G. Matera, L. Calzetta, P. Rogliani, F. Bardaro, C.P. Page, and M. Cazzola Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi Pulm. Pharmacol. Ther. 24 2011 221 226
34. M.G. Matera, L. Calzetta, A. Sanduzzi, C.P. Page, and M. Cazzola Effects of neuraminidase on equine isolated bronchi Pulm. Pharmacol. Ther. 21 2008 624 629
35. J. Meletiadis, J.W. Mouton, J.F. Meis, and P.E. Verweij In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates Antimicrob. Agents Chemother. 47 2003 106 117
36. H. Meurs, B.G. Dekkers, H. Maarsingh, A.J. Halayko, J. Zaagsma, and R. Gosens Muscarinic receptors on airway mesenchymal cells: novel findings for an ancient target Pulm. Pharmacol. Ther. 26 2013 145 155
37. H. Motulsky, and A. Christopoulos Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting 2004 Oxford University Press Oxford
38. G.J. Rodrigo, V. Plaza, and J.A. Castro-Rodriguez Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: a systematic review Pulm. Pharmacol. Ther. 25 2012 40 47
39. P. Rogliani, L. Calzetta, E.A. Rendina, D. Massullo, M. Dauri, B. Rinaldi, A. Capuano, and M.G. Matera The influence of propofol, remifentanil and lidocaine on the tone of human bronchial smooth muscle Pulm. Pharmacol. Ther. 26 2013 325 331
40. G. Rossoni, B. Manfredi, R. Razzetti, M. Civelli, and F. Berti Positive interaction of the novel beta2-agonist carmoterol and tiotropium bromide in the control of airway changes induced by different challenges in guinea-pigs Pulm. Pharmacol. Ther. 20 2007 250 257
41. D. Singh, P. Jones, E. Bateman, S. Korn, C. Serra, E. Molins, C. Caracta, E. Garcia Gil, and A. Leselbaum Evaluation of the efficacy and safety of two doses of aclidinium and formoterol in fixed-dose combination in patients with COPD: the ACLIFORM study Chest 145 2014 375A
42. G. Sturton, C. Persson, and P.J. Barnes Small airways: an important but neglected target in the treatment of obstructive airway diseases Trends Pharmacol. Sci. 29 2008 340 345
43. R.J. Tallarida Drug synergism: its detection and applications J. Pharmacol. Exp. Ther. 298 2001 865 872
44. D.P. Tashkin, and G.T. Ferguson Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease Respir. Res. 14 2013 49
45. E. van Lunteren, and M. Moyer Auxotonic contractile responses of rat tracheal and bronchial airway smooth muscle Pulm. Pharmacol. Ther. 14 2001 443 453
46. A. Wohlsen, S. Uhlig, and C. Martin Immediate allergic response in small airways Am. J. Respir. Crit. Care Med. 163 2001 1462 1469